{"id":"https://openalex.org/W1973374541","doi":"https://doi.org/10.1158/1078-0432.ccr-11-3086","title":"Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance","display_name":"Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance","publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W1973374541","doi":"https://doi.org/10.1158/1078-0432.ccr-11-3086","mag":"1973374541","pmid":"https://pubmed.ncbi.nlm.nih.gov/22550165","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3433236"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-11-3086","doi":"https://doi.org/10.1158/1078-0432.ccr-11-3086","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-3086","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3433236","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026962347","display_name":"Grazia Ambrosini","orcid":"https://orcid.org/0000-0002-3051-362X","observed_orcids":["https://orcid.org/0000-0002-3051-362X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Grazia Ambrosini","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075174884","display_name":"Christine A. Pratilas","orcid":"https://orcid.org/0000-0002-7116-0605","observed_orcids":["https://orcid.org/0000-0002-7116-0605"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine A. Pratilas","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006374965","display_name":"Li\u2010Xuan Qin","orcid":"https://orcid.org/0000-0002-9367-3807","observed_orcids":["https://orcid.org/0000-0002-9367-3807"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li-Xuan Qin","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048892227","display_name":"Madhavi Tadi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madhavi Tadi","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079178474","display_name":"Oliver Surriga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oliver Surriga","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086473468","display_name":"Richard D. Carvajal","orcid":"https://orcid.org/0000-0002-3796-1118","observed_orcids":["https://orcid.org/0000-0002-3796-1118"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard D. Carvajal","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Laboratory of New Drug Development and Department of Medicine, and Departments of 2Molecular Pharmacology and Chemistry and 3Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026962347"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":8.372,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.97925745,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"18","issue":"13","first_page":"3552","last_page":"3561"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gnaq-mutation","display_name":"GNAQ mutation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.7419999837875366},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mek-erk-signaling","display_name":"MEK/ERK signaling","score":0.8629999756813049},{"id":"https://openalex.org/keywords/ddx21","display_name":"DDX21","score":0.7760000228881836},{"id":"https://openalex.org/keywords/cdk5r1","display_name":"CDK5R1","score":0.9909999966621399},{"id":"https://openalex.org/keywords/c-jun","display_name":"c-Jun","score":0.8569999933242798},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.7630000114440918},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.8939999938011169},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8669999837875366},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2779176653","wikidata":"https://www.wikidata.org/wiki/Q18026236","display_name":"GNAQ","level":4,"score":0.9852762222290039},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.715466320514679},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.7007228136062622},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6826671361923218},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6272473335266113},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5893101692199707},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5523114204406738},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.5353451371192932},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.436795175075531},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4217190444469452},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.29608631134033203},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20996028184890747},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19967472553253174},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14258453249931335},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D014158","descriptor_name":"Transcription, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014604","descriptor_name":"Uveal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014604","descriptor_name":"Uveal Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D014604","descriptor_name":"Uveal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D014604","descriptor_name":"Uveal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020125","descriptor_name":"Mutation, Missense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020411","descriptor_name":"Oligonucleotide Array Sequence Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043802","descriptor_name":"GTP-Binding Protein alpha Subunits, Gq-G11","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044385","descriptor_name":"GTP-Binding Protein alpha Subunits","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-11-3086","doi":"https://doi.org/10.1158/1078-0432.ccr-11-3086","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-11-3086","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:22550165","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22550165","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2691842","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3433236","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3433236","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3433236","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2691842","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3433236","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4734519737","display_name":null,"funder_award_id":"K08-127350","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G6979918857","display_name":"Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma","funder_award_id":"K08CA127350","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1964628210","https://openalex.org/W1972151119","https://openalex.org/W1972952928","https://openalex.org/W1979775163","https://openalex.org/W1979910254","https://openalex.org/W1988019690","https://openalex.org/W2007002248","https://openalex.org/W2011945682","https://openalex.org/W2014955306","https://openalex.org/W2018262243","https://openalex.org/W2021960304","https://openalex.org/W2038683568","https://openalex.org/W2039885485","https://openalex.org/W2051144764","https://openalex.org/W2053520756","https://openalex.org/W2056419224","https://openalex.org/W2070382741","https://openalex.org/W2076591428","https://openalex.org/W2077517114","https://openalex.org/W2080686146","https://openalex.org/W2081098333","https://openalex.org/W2089465156","https://openalex.org/W2093712612","https://openalex.org/W2096439168","https://openalex.org/W2123414352","https://openalex.org/W2123611729","https://openalex.org/W2124301770","https://openalex.org/W2125372689","https://openalex.org/W2128445526","https://openalex.org/W2136701323","https://openalex.org/W2139248078","https://openalex.org/W2140633731","https://openalex.org/W2156602474","https://openalex.org/W2160130560","https://openalex.org/W2170138574","https://openalex.org/W2292658304","https://openalex.org/W2325011840","https://openalex.org/W2330270782","https://openalex.org/W4300883794"],"related_works":["https://openalex.org/W2886129477","https://openalex.org/W2332593577","https://openalex.org/W2150772498","https://openalex.org/W2039939270","https://openalex.org/W2090787537","https://openalex.org/W2948500780","https://openalex.org/W2144093895","https://openalex.org/W3083361140","https://openalex.org/W2886664644","https://openalex.org/W2978910850"],"abstract_inverted_index":{"PURPOSE:":[0],"Metastatic":[1],"uveal":[2,34,93,102,222],"melanoma":[3,103],"represents":[4],"the":[5,21,53,59,86,111,129,169,174,208,246],"most":[6],"common":[7],"intraocular":[8],"malignancy":[9],"with":[10,66,106,110,218],"very":[11],"poor":[12],"prognosis":[13],"and":[14,25,36,83,122,141,155,173,197,240],"no":[15],"effective":[16],"treatments.":[17],"Oncogenic":[18],"mutations":[19,108],"in":[20,30,92,128,191,213,236,252],"G-protein":[22],"\u03b1-subunit":[23],"q":[24],"11":[26],"have":[27,150],"been":[28],"described":[29],"about":[31],"85%":[32],"of":[33,48,62,80,89,101,131,160,210,216,230,249],"melanomas":[35],"confer":[37],"constitutive":[38],"activation.":[39],"Multiple":[40],"signaling":[41],"pathways":[42],"are":[43,163,189],"induced":[44],"as":[45],"a":[46,67,151,157,228],"consequence":[47],"GNAQ/11":[49,220],"activation,":[50],"which":[51],"include":[52],"MEK/ERK":[54],"kinase":[55,73,176],"cascade.":[56],"We":[57,97,144,183],"analyzed":[58],"transcriptional":[60,153],"profile":[61],"cell":[63,104,192,195],"lines":[64,105],"treated":[65,109],"mitogen-activated":[68],"protein":[69],"(MAP)/extracellular":[70],"signal-regulated":[71],"(ERK)":[72],"(MEK)":[74],"inhibitor":[75,113],"to":[76,84],"identify":[77],"gene":[78],"targets":[79],"activated":[81],"GNAQ":[82,107,147,237],"evaluate":[85],"biologic":[87,247],"importance":[88],"these":[90,187,211],"genes":[91,133,161,188,212,233],"melanoma.":[94,223],"EXPERIMENTAL":[95],"DESIGN:":[96],"conducted":[98],"microarray":[99],"analysis":[100],"MEK":[112,166,250],"selumetinib.":[114],"For":[115],"comparison,":[116],"we":[117,202],"used":[118],"cells":[119,123,149,239],"carrying":[120],"BRAF(V600E)":[121],"without":[124],"either":[125],"mutation.":[126],"Changes":[127],"expression":[130,209],"selected":[132],"were":[134],"then":[135],"confirmed":[136],"by":[137,165,234],"quantitative":[138],"real-time":[139],"PCR":[140],"immunoblotting.":[142],"RESULTS:":[143],"found":[145],"that":[146,162,186,204],"mutant":[148,221,238],"MEK-dependent":[152],"output":[154],"identified":[156],"unique":[158],"set":[159],"downregulated":[164],"inhibition,":[167],"including":[168],"RNA":[170],"helicase":[171],"DDX21":[172],"cyclin-dependent":[175],"regulator":[177],"CDK5R1":[178],"whereas":[179],"Jun":[180],"was":[181],"induced.":[182],"provide":[184,241],"evidence":[185],"involved":[190],"proliferation,":[193],"tumor":[194,214],"invasion,":[196],"drug":[198],"resistance,":[199],"respectively.":[200],"Furthermore,":[201],"show":[203],"selumetinib":[205,235],"treatment":[206],"regulates":[207],"tissues":[215],"patients":[217],"metastatic":[219],"CONCLUSIONS:":[224],"Our":[225],"findings":[226],"define":[227],"subset":[229],"transcriptionally":[231],"regulated":[232],"new":[242],"insights":[243],"into":[244],"understanding":[245],"effect":[248],"inhibition":[251],"this":[253],"disease.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}